The solute carrier 6 family of transporters

被引:180
|
作者
Broeer, Stefan [1 ]
Gether, Ulrik [2 ]
机构
[1] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia
[2] Univ Copenhagen, Panum Inst, Fac Hlth Sci, Mol Neuropharmacol Grp,Dept Neurosc & Pharmacol, Copenhagen, Denmark
关键词
monoamine transporters; antidepressants; transport mechanism; transporter pharmacology; AMINOBUTYRIC-ACID TRANSPORTER; HUMAN DOPAMINE TRANSPORTER; DEFICIT HYPERACTIVITY DISORDER; HUMAN SEROTONIN TRANSPORTER; HUMAN NORADRENALINE TRANSPORTER; INDUCED REVERSE TRANSPORT; HIGH-AFFINITY RECOGNITION; L-PROLINE TRANSPORTER; GLYCINE TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS;
D O I
10.1111/j.1476-5381.2012.01975.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The solute carrier 6 (SLC6) family of the human genome comprises transporters for neurotransmitters, amino acids, osmolytes and energy metabolites. Members of this family play critical roles in neurotransmission, cellular and whole body homeostasis. Malfunction or altered expression of these transporters is associated with a variety of diseases. Pharmacological inhibition of the neurotransmitter transporters in this family is an important strategy in the management of neurological and psychiatric disorders. This review provides an overview of the biochemical and pharmacological properties of the SLC6 family transporters. LINKED ARTICLES BJP published a themed section on Transporters in 2011. To view articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.2011.164.issue-7/issuetoc
引用
收藏
页码:256 / 278
页数:23
相关论文
共 50 条
  • [31] Mammalian Solute Carrier (SLC)-like transporters of Legionella pneumophila
    Ashley Best
    Snake Jones
    Yousef Abu Kwaik
    Scientific Reports, 8
  • [32] Selective Inhibition of Human Solute Carrier Transporters by Multikinase Inhibitors
    Johnston, Rosie A.
    Rawling, Tristan
    Chan, Ting
    Zhou, Fanfan
    Murray, Michael
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (11) : 1851 - 1857
  • [33] Inhibitory effects of apigenin and kaempferol on the essential solute carrier transporters
    Ting Chan
    Zhen Li
    Jian Zheng
    Florence Shin Gee Cheung
    Ling Zhu
    Fanfan Zhou
    World Journal of Pharmacology, 2013, (04) : 115 - 121
  • [34] Interactions of organophosphorus pesticides with solute carrier (SLC) drug transporters
    Chedik, Lisa
    Bruyere, Arnaud
    Fardel, Olivier
    XENOBIOTICA, 2019, 49 (03) : 363 - 374
  • [35] Solute carrier transporters: potential targets for digestive system neoplasms
    Xie, Jing
    Zhu, Xiao Yan
    Liu, Lu Ming
    Meng, Zhi Qiang
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 153 - 166
  • [36] Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive Review
    Anagnostakis, Filippos
    Kokkorakis, Michail
    Markouli, Mariam
    Piperi, Christina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [37] Transcellular movement of hydroxyurea is mediated by specific solute carrier transporters
    Walker, Aisha L.
    Franke, Ryan M.
    Sparreboom, Alex
    Ware, Russell E.
    EXPERIMENTAL HEMATOLOGY, 2011, 39 (04) : 446 - 456
  • [38] Solute carrier transporters: emerging central players in tumour immunotherapy
    Chen, Ruiqun
    Chen, Ligong
    TRENDS IN CELL BIOLOGY, 2022, 32 (03) : 186 - 201
  • [39] Molecular Modeling and Ligand Docking for Solute Carrier (SLC) Transporters
    Schlessinger, Avner
    Khuri, Natalia
    Giacomini, Kathleen M.
    Sali, Andrej
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (07) : 843 - 856
  • [40] Structure-Based Ligand Discovery for Solute Carrier Transporters
    Schlessinger, Avner
    BIOPHYSICAL JOURNAL, 2013, 104 (02) : 199A - 199A